DT’s Q4 results were largely in line with estimates as revenue declined by 6% y/y while EBITA was do...
Marimekko is set to report its Q4'25 results on Thursday, February 12.
Redeye is encouraged by Tagmaster’s solid earnings beat in the fourth quarter.
* Sales -4% & EBIT adj. SEK 5m below vs. ABGSCe * Strong quarter for FM&WM, weaker for Decommissioni...
Redeye comments on Transtema’s Q4 report, showing numbers aligning with the preliminary figures.
Redeye comments on Fractal Gaming Group’s Q4 2025 report, which came in below our expectations.
Redeye comments on Dynavox’s Q4 report released earlier this morning, which delivered another set of...
Sales -13% vs. ABGSCe, EBIT SEK 7.6m vs. ABGSCe 9.4m * Three coating products launched in Korea in Q...
Redeye comments on Freja’s Q4, showing solid numbers in line with the preliminary figures.
Bactiguard reported Q4 net sales of SEK 63m (SEB at SEK 49m) with organic net sales growth of 4% y/y...
Redeye provides an update following Coffee Stain Group’s Q3 2025/2026 report, which delivered strong...
Aktia reported a Q4 PPP of EUR 19.8m, some 2% below consensus.
Redeye provides an update following Q-linea’s Q4 2025 report.
Redeye has updated its estimates and valuation for Sleep Cycle following the Q4 2025 report.
Redeye leaves a comment following OncoZenge’s announcement of the completed readout from its UCLA-le...
Raute reports Q4 results on Feb 12. Wood Processing has already demonstrated very high margins so th...
Sleep Cycle’s Q4 report was in line with our top-line expectations but revealed a steeper-than-antic...
Redeye provides an initial take following Q-linea’s Q4 2025 report.
While the current valuation profile of Vitrolife requires more than the current stagnant growth prof...
Redeye updates on Invisio ahead of Q4-results (due 12 February) where we expect the company to end t...
